| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.6B | $8.7B | $9.0B | $9.0B | $8.7B | $2.2B | $2.1B | $1.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $4.5B | $4.6B | $4.8B | $4.9B | $4.8B | $4.5B | $4.4B | — |
| R&D Expense | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.1B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.5B | $-1.5B | $1.9B | $2.0B | $2.0B | $-0.5B | $0.4B | $0.5B |
| Net Income | $0.8B | $-1.7B | $1.3B | $1.2B | $1.3B | $-0.7B | $0.2B | $0.3B |
| EPS (Basic) | $2.38 | $-6.14 | $0.33 | $0.31 | $0.32 | $-0.16 | $0.05 | $0.06 |
| EPS (Diluted) | $2.23 | $-6.14 | $0.32 | $0.31 | $0.32 | $-0.16 | $0.05 | $0.06 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $27.2B | $27.5B | $10.4B | $10.0B | $10.3B | $10.3B | $11.1B | $8.2B |
| Current Assets | $1.1B | $1.1B | $1.3B | $1.0B | $1.2B | $1.0B | $1.0B | $0.5B |
| Cash & Equivalents | $0.1B | $0.2B | $0.2B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $15.7B | $16.4B | $12.9B | $13.4B | $12.9B | $12.6B | $11.9B | $10.0B |
| Current Liabilities | $3.7B | $2.7B | $3.2B | $3.0B | $3.0B | $3.2B | $3.3B | $2.8B |
| Stockholders' Equity | $11.6B | $11.1B | $-2.6B | $-3.4B | $-2.6B | $-2.3B | $-0.7B | $-1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.9B | $1.7B | $1.9B | $2.0B | $2.0B | $2.0B | $2.0B | $1.9B |
| Investing Cash Flow | $-0.7B | $-1.0B | $-0.7B | $-0.5B | $-0.2B | $-0.7B | $-0.0B | $-0.4B |
| Capital Expenditures | $0.7B | $0.7B | $0.7B | $0.4B | $0.4B | $0.3B | $0.4B | $0.4B |
| Financing Cash Flow | $-1.2B | $-0.9B | $-1.0B | $-1.6B | $-1.7B | $-1.3B | $-2.0B | $-1.5B |